Callan Family Office’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
9,333
+250
+3% +$27.6K 0.02% 582
2026
Q1
$998K Sell
9,083
-670
-7% -$71.6K 0.02% 558
2025
Q4
$974K Buy
9,753
+3,213
+49% +$329K 0.02% 554
2025
Q3
$683K Sell
6,540
-954
-13% -$95.2K 0.02% 456
2025
Q2
$720K Buy
7,494
+4,124
+122% +$400K 0.02% 474
2025
Q1
$338K Buy
3,370
+19
+0.6% +$1.83K 0.03% 399
2024
Q4
$299K Buy
+3,351
New +$300K 0.02% 484

Other funds holding AEE

Callan Family Office's AEE Position: Q2 2026 in Review

Callan Family Office increased its Ameren (AEE) stake by 2.8% in Q2 2026, buying an estimated $27.6K and bringing the position to 9,333 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #582.

Callan Family Office first reported a position in AEE in Q4 2024 and has held it in 7 quarters since. 954 funds tracked by Wall St. Rank hold AEE as of Q2 2026.

  • Callan Family Office held 9,333 shares of Ameren worth $1.06M as of Q2 2026.
  • Callan Family Office bought 250 Ameren shares in Q2 2026, an estimated $27.6K.
  • Ameren made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #582 holding.
  • Callan Family Office first reported a position in Ameren in Q4 2024 and has held it in 7 quarters since.
  • 954 funds tracked by Wall St. Rank held Ameren as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.